Acough, UCL and arm come together to offer more cloud computing capabilities for life sciences Applications
Paris France – June 1St., 2022 – Atos and UCL today announce that they have successfully run the virus sequencing tool, Viridian, used to detect the mutation of the SARS-Cov-2 strain of coronavirus, using an Arm®-based Ampere® Altra® processor in an environment cloud native with Atos integration expertise. This proof of concept (PoC) was coordinated by Atos’ life sciences Center of excellence whose goal is to foster a culture of exploration, discovery and co-creation to harness the power of digital technologies to advance precision health and accelerate drug discovery and development.
With data growing exponentially and becoming more difficult to process for life science applications, scientists rely on high-performance computing and parallel computing to rapidly process and analyze massive amounts of data.
The Arm Neoverse™-based platform, Ampere Altra, is dedicated to cloud-native workloads, which means that simulation and results can be achieved not only on-premises but directly in the cloud, on any kind of environment. HPC platform and from anywhere.
With more and more labs using Arm-based solutions, this successful PoC means that they will now be able to run Viridian on their systems, allowing them to study life science workflows and detect various mutations in the SARS-CoV genome. 2, in order to finally help fight COVID-19.
This work has combined the expertise of a team of experts from Atos and Arm focused on hardware and software optimizations, together with a scientific team from UCL dedicated to scientific applications for these specific use cases. This collaboration has enabled optimization of both the software and hardware in this co-design effort to meet the demands of cutting-edge, impactful genomics workflows, already being implemented in clinical settings.
immanuelleroux, Group Senior Vice President, Global Head of HPC, AI and Quantum in atos, commented “To be the undisputed European leader on HPC it’s not just about delivery most systems to European HPC centers in terms of petaflops but also about labor closely with numerous European scientific and research institutions to empower several production of crucial data and daily simulations. This work, under the umbrella of the Atos de Ex Life Sciences CenterCelence, demonstrates that collaboration between academia and industry through the power of supercomputing is creating new avenues for scientific advances. This daywe have one more time shown the importance of hybrid computing to foster innovation and provide scientists with tangible applications of the life sciences.”
alex Wade, Associate Researcher at UCL, said: “This co-design effort between Arm, Atos and UCL has enabled the optimization of both Arm’s new hardware and cutting-edge genomics software, strengthening both for real-world life sciences applications. Collaboration with industry partners has demonstrated a key insight for the future of HPC applications where hardware and software are tuned for performance together, as opposed to the typical history of software being continually updated so that match newer hardware versions. This work has been carried out as part of the Center of Excellence in Computational Biomedicine (CompBioMed) and was made possible by by CompBioMed extensive interdisciplinary knowledge. Arm and Atos were valuable partners in this to work and we hope that this work will lead to future collaborations and can act as a model for other co-design activities..”
Atos is a global leader in digital transformation with 111,000 employees and annual revenue of c. 11 billion euros. Number one in Europe in cybersecurity, cloud and high-performance computing, the Group offers comprehensive tailor-made solutions for all industries in 71 countries. A pioneer in decarbonisation services and products, Atos is committed to a secure and decarbonised digital environment for its clients. Atos is an SE (Societas Europaea), listed on Euronext Paris and included in the CAC 40 ESG and Next 20 Paris stock indices.
the Purpose of Athos is to help design the future of the information space. Its experience and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Around the world, the Group enables its customers and employees, and members of societies in general, to live, work and develop sustainably, in a safe and secure information space.
Constance Arnoux | email@example.com | +33 (0)6 44 12 16 35
- PR – Atos, UCL and Arm join forces to offer greater cloud computing possibilities for life sciences applications